Polymorphisms in themannose binding lectin-2gene... : Critical Care Medicine (original) (raw)
Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome*
- Michelle N. Gong
- Wei Zhou
- Paige L. Williams
- Taylor B Thompson
- Lucille Pothier
- David C. Christiani
Critical Care Medicine
35
(
1
)
:p
48
-
56
,
January 2007
.
| DOI: 10.1097/01.CCM.0000251132.10689.F3
Objective:
The variant alleles in the mannose binding lectin-2 (MBL-2) gene have been associated with MBL deficiency and increased susceptibility to sepsis. We postulate that the variant MBL-2 genotypes are associated with increased susceptibility to and mortality in acute respiratory distress syndrome (ARDS).
Design:
Nested case-control study.
Setting:
Tertiary academic medical center.
Patients:
Two hundred and twelve Caucasians with ARDS and 442 controls genotyped for the variant X, D, B, and C alleles of codon −221, 52, 54, and 57, respectively.
Interventions:
None.
Measurements and Main Results:
Patients homozygous for the variant codon 54B allele (54BB) had worse severity of illness on admission (p = .007), greater likelihood of septic shock (p = .04), and increased odds of ARDS (adjusted odds ratio, 6.7; 95% confidence interval, 1.5–31) when compared with heterozygotes and homozygotes for the wild-type allele. This association with ARDS was especially strong among the 311 patients with septic shock (adjusted odds ratio, 12.0; 95% confidence interval, 1.9–74). Among the patients with ARDS, the 54BB genotype was associated with more daily organ dysfunction (p = .01) and higher mortality (adjusted hazard rate, 4.0; 95% confidence interval, 1.6–10). Development of ARDS and outcomes in ARDS did not vary significantly with variant alleles of codon −221, 52, and 57, but the power to detect an effect was limited secondary to the low allele frequencies.
Conclusions:
The MBL-2 codon 54BB genotype may be important in ARDS susceptibility and outcome. Additional studies are needed to confirm these findings in other populations.
Copyright © by 2007 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.